Independent Advisor Alliance Reduces Position in iShares Core SP 500 ETF
| GBFFX Fund | USD 19.44 0.01 0.05% |
Slightly above 56% of Gmo Benchmark-free's investor base is looking to short. The analysis of overall sentiment of trading Gmo Benchmark Free Fund mutual fund suggests that many investors are alarmed at this time. Gmo Benchmark-free's investing sentiment can be driven by a variety of factors including economic data, Gmo Benchmark-free's earnings reports, geopolitical events, and overall market trends.
Gmo |
Independent Advisor Alliance lessened its stake in shares of iShares Core SP 500 ETF by 5.3 percent in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,190 shares of the companys stock after selling 343 shares during the quarter. Independent
Read at thelincolnianonline.com
 |
Gmo Benchmark-free Fundamental Analysis
We analyze Gmo Benchmark-free's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gmo Benchmark-free using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gmo Benchmark-free based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Gmo Benchmark is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Gmo Benchmark Free Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gmo Benchmark-free mutual fund to make a market-neutral strategy. Peer analysis of Gmo Benchmark-free could also be used in its relative valuation, which is a method of valuing Gmo Benchmark-free by comparing valuation metrics with similar companies.
Peers
Gmo Benchmark-free Related Equities
| IOVFX | Gmo International | 1.13 | ||||
| GWOAX | Gmo Global | 0.82 | ||||
| GEACX | Gmo Trust | 0.60 | ||||
| GEMNX | Gmo Emerging | 0.45 | ||||
| GEMMX | Gmo Emerging | 0.42 | ||||
| GEMEX | Gmo Emerging | 0.41 | ||||
| GUGAX | Gmo E | 0.28 | ||||
| GHVIX | Gmo High | 0.22 | ||||
| GUSTX | Gmo Treasury | 0.00 | ||||
| GUSOX | Gmo Trust | 0.12 |
Other Information on Investing in Gmo Mutual Fund
Gmo Benchmark-free financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Benchmark-free security.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |